IMAX Medical

Based in France, IMAX Medical specializes in advanced medical devices and solutions, aiming to enhance patient outcomes across various healthcare environments through innovative technology. IMAX Medical, founded in 2012, is located in Nantes, France, and focuses on developing medical devices intended for hospitals and clinics. In February 2021, the company was acquired by Probo Medical, LLC, which will enable IMAX Medical to provide an expanded range of solutions to its clients. The CEO is Simon Roussel.

IMAX Medical specializes in providing advanced medical devices and solutions tailored to enhance patient outcomes in various healthcare settings. Their core product offerings include innovative diagnostic tools, therapeutic equipment, and patient monitoring systems designed to address critical health challenges. These products are engineered for use in hospitals, clinics, and outpatient facilities, catering primarily to healthcare professionals and institutions that require reliable and effective medical solutions. The company has positioned its products within key geographical markets including Europe, North America, and parts of Asia, focusing on regions that prioritize advanced healthcare technology and improved patient care capabilities.

IMAX Medical generates revenue through a combination of direct sales and strategic partnerships with healthcare providers and distributors. Transactions typically involve a B2B model where hospitals and clinics procure their flagship medical devices on a contractual basis, often including service agreements for ongoing support and maintenance. Pricing structures are based on specific product lines, which include both one-time purchases and subscription-based services for continual updates and customer support. The company’s revenue streams are further bolstered by collaborations with healthcare professionals, ensuring that their products meet the evolving needs of clinicians and patients in the market.

Following its acquisition by Probo Medical, LLC in February 2021, IMAX Medical plans to leverage this partnership to enhance its product offerings and expand into new geographical markets. The acquisition is expected to provide IMAX Medical with the opportunity to develop and launch new medical devices, broadening their portfolio. The company aims to capitalize on the expanded capabilities and resources available through Probo Medical to target growth in Europe, North America, and select Asian markets in the coming years.